Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | S1PR1 | P21453 | 2/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | PIK3C2A | O00443 | 1/20 | 0.33 |
| ▸ | PIK3C2B | O00750 | 1/20 | 0.33 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.33 |
| ▸ | MTOR | P42345 | 1/20 | 0.33 |
| ▸ | TRPM8 | Q7Z2W7 | 1/20 | 0.31 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.30 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.30 |
| ▸ | LRRK2 | Q5S007 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30122069 | 1.00 | CYP1A2 (0.35) | CYP1A2S1PR1ALDH1A1PIK3C2APIK3C2B | |
| SCHEMBL21586223 | 1.00 | CYP1A2 (0.35) | CYP1A2S1PR1ALDH1A1PIK3C2APIK3C2B | |
| SCHEMBL30402935 | 1.00 | CYP1A2 (0.35) | CYP1A2S1PR1ALDH1A1PIK3C2APIK3C2B | |
| SCHEMBL17529570 | 0.92 | CYP1A2 (0.36) | CYP1A2S1PR1ALDH1A1PIK3C2APIK3C2B | |
| SCHEMBL30402347 | 0.88 | CYP1A2 (0.32) | CYP1A2ALDH1A1PIK3C2APIK3C2BPIK3CA | |
| SCHEMBL21586182 | 0.88 | CYP1A2 (0.32) | CYP1A2ALDH1A1PIK3C2APIK3C2BPIK3CA | |
| SCHEMBL24695537 | 0.87 | S1PR1 (0.33) | S1PR1PIK3C2APIK3C2BPIK3CAMTOR | |
| SCHEMBL30122167 | 0.87 | S1PR1 (0.33) | S1PR1PIK3C2APIK3C2BPIK3CAMTOR | |
| SCHEMBL30122216 | 0.87 | S1PR1 (0.33) | S1PR1PIK3C2APIK3C2BPIK3CAMTOR | |
| SCHEMBL25517849 | 0.86 | AGPAT2 (0.38) | CYP1A2S1PR1ALDH1A1PIK3CATRPM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4347591-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFOXIMINE CONTAINING SUBSTITUENTS | Syngenta Crop Protection AG (CH) | 2024-04-10 | — | — | EP | claimed |
| WO-2022253841-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFOXIMINE CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2022-12-08 | — | — | WO | claimed |
| US-20250081967-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFOXIMINE CONTAINING SUBSTITUENTS | SYNGENTA CROP PROTECTION AG (CH) | 2025-03-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250081967-A1 | PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULFOXIMINE CONTAINING SUBSTITUENTS | DDT, AADAC, SMOX | CYP1A2 348/4885S1PR1 862/4885ALDH1A1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.